BC
RCUS icon

Boxer Capital’s Arcus Biosciences RCUS Stock Holding History

Boxer Capital’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,602,200
Closed -$24.5M – 43
2024
Q3 		$24.5M Hold
1,602,200
– – 1.2% 22
2024
Q2 		$24.4M Hold
1,602,200
– – 1.29% 24
2024
Q1 		$30.2M Hold
1,602,200
– – 1.49% 20
2023
Q4 		$30.6M Hold
1,602,200
– – 1.53% 21
2023
Q3 		$28.8M Hold
1,602,200
– – 1.53% 24
2023
Q2 		$32.5M Buy
1,602,200
+170,000
+12% +$3.24M 1.51% 20
2023
Q1 		$26.1M Hold
1,432,200
– – 1.28% 25
2022
Q4 		$29.6M Hold
1,432,200
– – 1.56% 21
2022
Q3 		$37.5M Hold
1,432,200
– – 2.11% 16
2022
Q2 		$36.3M Hold
1,432,200
– – 2.3% 17
2022
Q1 		$45.2M Hold
1,432,200
– – 2.32% 15
2021
Q4 		$58M Sell
1,432,200
-652,683
-31% -$25.3M 2.25% 14
2021
Q3 		$72.7M Hold
2,084,883
– – 2.54% 9
2021
Q2 		$57.3M Hold
2,084,883
– – 2.02% 10
2021
Q1 		$58.5M Hold
2,084,883
– – 1.99% 10
2020
Q4 		$54.1M Hold
2,084,883
– – 1.74% 14
2020
Q3 		$35.7M Hold
2,084,883
– – 1.23% 19
2020
Q2 		$51.6M Sell
2,084,883
-1,000,000
-32% -$27M 2.27% 10
2020
Q1 		$42.8M Buy
3,084,883
+1,412,650
+84% +$17.6M 2.92% 11
2019
Q4 		$16.9M Buy
1,672,233
+1,372,233
+457% +$11.5M 0.96% 30
2019
Q3 		$2.73M Buy
+300,000
New +$2.41M 0.2% 43

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Boxer Capital's RCUS Position: Q4 2024 in Review

Boxer Capital sold out of Arcus Biosciences (RCUS) in Q4 2024, closing a stake of 1,602,200 shares — an estimated $24.5M sold.

Boxer Capital first reported a position in RCUS in Q3 2019 and held it in 21 quarters. The position peaked at $72.7M in Q3 2021. 186 funds tracked by Wall St. Rank hold RCUS as of Q4 2024.

  • Boxer Capital reported no remaining Arcus Biosciences position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 1,602,200 Arcus Biosciences shares in Q4 2024, an estimated $24.5M.
  • Boxer Capital first reported a position in Arcus Biosciences in Q3 2019 and held it in 21 quarters.
  • Boxer Capital's Arcus Biosciences position peaked at $72.7M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.